Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients

NCT01939054 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Nimotuzumab
DRUG: docetaxel
DRUG: capecitabine

Sponsor

Chinese Academy of Medical Sciences

Collaborators

[object Object]